ARCHIVES

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

This article is from The Cancer Letter archive.

Vol. 06 No. 24 | June 13, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

July 11, 2014

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014